Nrgene Technologies Ltd · TASE:NRGN
Nrgene Technologies — Investor Presentation (August 2023)
23 slides from Nrgene Technologies's investor presentation, August 2023
Slide 1: Capital Markets Presentation
Capital Markets Presentation AUGUST 2023
Slide 2: Disclaimer
Disclaimer • The objective of this presentation is to present the activity of NRGene Technologies Ltd. (the “Company”) and to provide preliminary and basic information regarding its activities. In accessing this presentation, you agree to be bound by the following terms and conditions. • This presen
Slide 3: Agenda
Agenda • About NRGene • NRGene’s Technology • The Company’s Activities • Business Models • Innovative End-Products Development • IP Development Projects in Return for Royalties • Global Trends Impacting the Company’s Activities • 2022 Financial Results Highlights © 2 0 2 3 AL L R I G H T S R E S E R
Slide 4: About NRGene
About NRGene NRGene Technologies Ltd. is an AgTech company engaged in research and development of IP- based technological products. The company develops varieties and traits of crops and animals, using its technology in the field of artificial intelligence (AI), to analyze genetic information based
Slide 5: NRGene's AI Technology Was Validated by Leading Companies Worldwide
NRGene’s Artificial Intelligence (AI) Technology 2015 Launch of genomics was Validated by Leading Companies Worldwide analysis solutions (services) A proven technology that has been successfully implemented in over 300 projects across various industries 2017 Multi-year subscription agreements of the
Slide 6: NRGene's Technology
NRGene’s Technology TM BREEDING.AI The benefits AI Technologies Crops and Animals Breeding Reduces development time Reduces costs Multi-year Data: Increases likelihood • Field performance of success • Climate • Genomics data • Soil and Irrigation NEW ENRICHED VARIETY • Pests and diseases 1st 2
Slide 7: The Company's Activities
The Company’s Activities AI Technology A cloud-based analytical platform with proven results in hundreds of projects B R E E D I NG . AI TM across dozens of species (crops and animals). The system predicts improved genetic combinations and provides optimized and accurate natural AI Technology breedi
Slide 8: Business Models
Business Models Subscription agreements and IP development of genomics analysis services traits and varieties TM B R E E D I NG . AI • Strategic Collaborations Crops and Animals AI Technology Cocoa Coffee • Genotyping (DNA tests) Computational Tools For Crops and Revenues from royalties Genomics Ana
Slide 9: NRGene Engages in Partnerships to Develop Varieties and Commercialize End-Products
NRGene Engages in Partnerships to Develop Varieties and Commercialize End-Products Strategic collaborations ensure a complete presence in the agriculture value chain and maximizing value creation for the end-customer Strategic partner Varieties Seed Farmers Packaging Distribution End-customer develo
Slide 10: Innovative End-product Development in Emerging Markets
Innovative End-product Development in Emerging Markets Project | Partner … 2022 2023 2024 2025 2026 … 2030 IP development business model in return for end-product sales* Black Soldier Fly (BSF) as an alternative to animal-based 2024: revenues from end-product sales 2022: Development by NRGene New/un
Slide 11: Black Soldier Fly (BSF) as an Alternative to Animal-Based Protein Sources
Black Soldier Fly (BSF) as an Alternative to Animal-Based Protein Sources 2022 Development of BSF’s genomics infrastructure Animal feed derived from insects is considered nutritious, healthy, and sustainable. Project Goal: reducing the larvae manufacturing costs through improved new BSF varieties. J
Slide 12: Black Soldier Fly Project Progress Status
Project progress status Black Soldier Fly (BSF) as an Alternative to Animal-Based Protein Source • The company has collaborated with the Buhler company, a leading global manufacturer of animal feed equipment, to provide an end-to-end solution to customers in the industry who produce BSF larvae as an
Slide 13: Cherry Tomato Varieties for the Frozen Food and Catering Market
Cherry Tomato Varieties for the Frozen Food and Catering Market February 2022 Project launch Project Goal: Expanding the use of "semi-dried" tomatoes by developing and commercializing higher-quality tomato varieties. Marketing frozen tomatoes reduces loss in the entire supply chain November 2022 Alp
Slide 14: Seedlings Grown in Vertical Farming for Dairy Cattle Feed
Seedlings Grown in Vertical Farming for Dairy Cattle Feed August 2022 Collaboration agreement with Granot Group Strategic collaboration with the Granot Group to develop and commercialize elite wheat varieties and dairy cattle feed using vertical farming* November 2022 First milestone: identification
Slide 15: IP Development Projects in Return for Royalties - Status
IP Development Projects in Return for Royalties - Status Project | Partner … 2022 2023 2024 2025 2026 … 2030 ToBRFV resistance in 2020: Development by NRGene 2022: Commercialization and implementation 2024: Royalties tomatoes | Philoseed Alternative protein from Pea and Hemp 2021: Development by NRG
Slide 16: IP Development Projects in Return for Royalties
IP Development Projects in Return for Royalties The revenue potential in significant projects (to date): Potential annual Project Expected Expected year Expected royalties (throughout Commercialization status market size development period* of initial royalties the project's lifetime)*** (seeds/vari
Slide 17: IP Development Projects Progress Status
Project progress status IP Development Projects in Return for Royalties • A milestone has been reached in the development of the virus resistance trait, with customers reporting high virus resistance in plants they grow using company seeds. • Together with its partner in the project, Philoseed, the
Slide 18: Asset Purchase Agreement and Grant of Licenses to Above Food
Project progress status Asset Purchase Agreement and Grant of Licenses for Technology and Projects to Above Food The agreement's main terms and conditions • Below is an overview of the main assets, technology and projects that will be transferred to Above Food: A non-exclusive and non- Mapping and D
Slide 19: Genotyping (DNA Tests)
Genotyping (DNA Tests) Leveraging NRGene's technology to generate recurring revenue through long-term engagements with customers Overview of genotyping’s market penetration (starting in Q4, 2020) $3.6M 12 $0.7M Total booking* Number of genotyping New agreements during H1 customers To clarity, the ge
Slide 20: Food Security and Sustainability
Food Security and Sustainability Global Trends Impacting the Company’s Activities Global Climate Alternatives to meat food crisis change and healthy food NRGene's technology increases agricultural Increasing populations and Reduction in arable land and The negative impact of animal- productivity, wh
Slide 21: Financial Results Highlights (US Dollars in Thousands)
Financial Results Highlights* (US Dollars in Thousands) Financial data H1 - 2023 H1 - 2022 FY - 2022 Comments End of subscription agreement with Syngenta (January 2023) which led to a Revenues 1,149 1,486 3,159 decrease in revenues from providing access to software, partially offset by first revenue
Slide 22: NRGene's Future Focus
NRGene’s Future Focus Commercialization / Expected commercialization date Project/Model | Partner 2023 2024 2025 Subscription agreements and genomics analysis services ToBRFV resistance in tomatoes | Philoseed IP Development Projects in Return for Royalties Alternative protein from Pea and Hemp | PI
Slide 23: Questions?
Questions? NRGene Ltd. @NRGene nrgene.com info@nrgene.com Thank you! 23
NRGene Technologies — Investor Presentation (August 2023) on 6ix